![Marc d'Abbadie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc d'Abbadie
Directeur/Bestuurslid bij Spark Nw Carry Partner LLP
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Susan Foden | M | 71 | 10 jaar | |
Stephen Bloor | M | - |
Videregen Ltd.
![]() Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | 13 jaar |
Alan Barge | M | - | 9 jaar | |
Jonathan Charles Gee | M | 71 |
SPARK Impact Ltd.
![]() SPARK Impact Ltd. Investment ManagersFinance SPARK Impact Ltd (SPARK Impact) is a venture capital firm founded in 2010. The firm is headquartered in North East, United Kingdom. | - |
Martin Hunt | M | 66 |
Videregen Ltd.
![]() Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | - |
Douglas Quinn | M | 69 |
Videregen Ltd.
![]() Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | - |
Mark Borzomato | M | - |
SPARK Impact Ltd.
![]() SPARK Impact Ltd. Investment ManagersFinance SPARK Impact Ltd (SPARK Impact) is a venture capital firm founded in 2010. The firm is headquartered in North East, United Kingdom. | 8 jaar |
Robert Hollamby | M | - |
Videregen Ltd.
![]() Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Richard Moulson | M | - | - | |
John Bradshaw | M | 60 | - | |
Susan Clement Davies | F | 62 | 5 jaar | |
Mark A. Wyatt | M | 51 | - | |
Hamina J. Patel | F | - | - | |
David Chadwick | M | - | 3 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigd Koninkrijk | 14 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Marc d'Abbadie
- Persoonlijk netwerk